Virosomes for antigen and DNA delivery.
Specific targeting and delivery as well as the display of antigens on the surface of professional antigen-presenting cells (APCs) are key issues in the design and development of new-generation vaccines aimed at the induction of both humoral and cell-mediated immunity. Prophylactic vaccination against infectious diseases in general aims at the induction of humoral immune responses to prevent infection. This humoral immune response is mediated by antibody-producing B cells. On the other hand, therapeutic immunisation against virally infected cells and tumour cells requires the induction of cytotoxic T lymphocytes (CTLs) that can specifically recognise and lyse infected cells or transformed tumour cells. The induction of Major Histocompatibility Complex (MHC) class I restricted CTL activity is optimally achieved by synthesis of antigens within APCs, for example, after immunisation with live attenuated virus. However, immunisation with live vaccines bears the risk of causing disease. Therefore, alternative vaccine delivery systems, which enable introduction of nonreplicating antigen into the MHC class I presentation pathway, are sought. Furthermore, for the induction of effective humoral and cellular responses, MHC class II restricted activation of T helper cells (Th cells) is required. Among other delivery systems, as described in this theme issue of Advanced Drug Delivery Reviews, virosomes seem ideally suited for delivery of antigens into both MHC pathways. In this review, we will focus on the use of virosomes as carrier vehicles for the intracellular delivery of protein antigens and DNA, and the induction of a cellular immune response against encapsulated protein antigens and proteins expressed by virosome-associated plasmids.
Daemen
Toos
T
Department of Medical Microbiology, Molecular Virology Section, University of Groningen, Anthonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. c.a.h.h.daemen@med.rug.nl
de Mare
Arjan
A
Bungener
Laura
L
de Jonge
Jørgen
J
Huckriede
Anke
A
Wilschut
Jan
J
D000818:Animals; D017951:Antigen Presentation; D000941:Antigens / Q000008:administration & dosage*; D003600:Cytosol / Q000378:metabolism; D006801:Humans; D007114:Immunization; D008561:Membrane Fusion; D009975:Orthomyxoviridae; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000276:immunology; D022701:Virosomes
D000941:Antigens; D019444:Vaccines, DNA; D022701:Virosomes